LY2886721
LY2886721 is a potent and selective BACE1 inhibitor developed for Alzheimer's disease research. It has been utilized in both in vitro enzymatic assays and in vivo preclinical models to investigate the inhibition of amyloid-beta peptide production and its potential therapeutic effects.
Product Specifications
CAS Number
1262036-50-9
Product Name Alternative
SAPPβ, βSecretase, β-Secretase, Alzheimer's, BBB, Beta-secretase, BetaSecretase, b-Secretase, bSecretase, C99, BACE, BACE1, BACE2, disease, Inhibitor, inhibit, LY2886721, LY-2886721, LY 2886721
Field of Research
Neuroscience
Purity
99.00% (May vary between batches)
Solubility
DMSO:1 mg/mL (2.56 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble)
Smiles
NC1=N[C@]2 (COC[C@H]2CS1) c1cc (NC (=O) c2ccc (F) cn2) ccc1F
Molecular Formula
C18H16F2N4O2S
Molecular Weight
390.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
CD02355-01 10 µg
Recombinant Human Alpha-amylase 2B protein (C-6His)
Sign In for Pricing
View Details